Pressure BioSciences, Inc.
PBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $7,701 | $14,376 | $15,330 | $7,005 |
| - Cash | $81 | $4 | $132 | $19 |
| + Debt | $22,886 | $20,530 | $14,642 | $9,596 |
| Enterprise Value | $30,506 | $34,902 | $29,840 | $16,582 |
| Revenue | $1,978 | $1,729 | $2,002 | $1,221 |
| % Growth | 14.4% | -13.6% | 64% | – |
| Gross Profit | $800 | -$285 | $1,060 | $638 |
| % Margin | 40.4% | -16.5% | 52.9% | 52.2% |
| EBITDA | -$9,391 | -$5,405 | -$5,528 | -$7,457 |
| % Margin | -474.8% | -312.5% | -276.1% | -611% |
| Net Income | -$29,314 | -$16,077 | -$20,153 | -$16,006 |
| % Margin | -1,482.2% | -929.6% | -1,006.5% | -1,311.3% |
| EPS Diluted | -1.51 | -1.61 | -3.42 | -5.32 |
| % Growth | 6.2% | 52.9% | 35.7% | – |
| Operating Cash Flow | -$3,186 | -$4,478 | -$4,869 | -$4,883 |
| Capital Expenditures | -$7 | -$21 | -$123 | -$2 |
| Free Cash Flow | -$3,194 | -$4,499 | -$4,992 | -$4,885 |